Search Within

Ellen Marlese Basu

Formats
  1. Meeting Abstract (57)
  2. Journal Article (43)
  3. Correspondence (1)
Groups
  1. Neuroblastoma Service (101)
  2. Pediatrics, Department of (101)
  3. GSK Faculty (64)
  4. Tow Center for Developmental Oncology (TCDO) (63)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)
  6. Neuro-Oncology Service (41)

More Groups

People
  1. Shakeel Modak (76)
  2. Brian Kushner (68)
  3. Stephen Roberts (64)
  4. Nai-Kong Cheung (61)
  5. Kim Kramer (37)
  6. Suzanne Wolden (20)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (7)
  6. 2020 (13)

More Years

Publications
  1. Pediatric Blood and Cancer (36)
  2. Journal of Clinical Oncology (17)
  3. Neuro-Oncology (8)
  4. International Journal of Radiation Oncology, Biology, Physics (5)
  5. Cancer (4)
  6. International Journal of Cancer (4)

More Publications

Publishers
  1. Wiley Periodicals, Inc (36)
  2. American Society of Clinical Oncology (18)
  3. Oxford University Press (9)
  4. Elsevier Inc. (6)
  5. John Wiley & Sons (4)
  6. Wiley Blackwell (4)

More Publishers

Results (101)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1/2 trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Desai, A. V.; Gajjar, A.; Gauvain, K.; Basu, E. M.; Macy, M. E.; Maese, L.; Sabnis, A. J.; Foster, J.; Shusterman, S.; Yoon, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Robinson, G. W.; Gajjar, A. J.; Gauvain, K. M.; Basu, E. M.; Macy, M. E.; Maese, L. D.; Sabnis, A. J.; Foster, J. H.; Shusterman, S.; Yoon, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save